Authors' reply
Lancet Respir Med
.
2022 Jan;10(1):e4.
doi: 10.1016/S2213-2600(21)00493-8.
Authors
Jean-Marc Naccache
1
,
Marine Cachanado
2
,
Alexandra Rousseau
2
,
Hilario Nunes
3
Affiliations
1
Service de Pneumologie, Groupe Hospitalier Paris Saint Joseph, Paris, France. Electronic address: jmnaccache@ghpsj.fr.
2
Department of Clinical Pharmacology and Clinical Research Platform of the East of Paris, APHP, Hôpital St Antoine, Paris, France.
3
APHP, Service de Pneumologie, Centre Constitutif Maladies Pulmonaires Rares de l'Adulte, Hôpital Avicenne, Bobigny, Paris, France.
PMID:
34973213
DOI:
10.1016/S2213-2600(21)00493-8
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment